512217 — Prism Medico and Pharmacy Income Statement
0.000.00%
Last trade - 00:00
- IN₹157.65m
- IN₹156.85m
- IN₹29.25m
- 32
- 18
- 63
- 26
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 269 | 168 | 84.4 | 12.7 | 29.3 |
Cost of Revenue | |||||
Gross Profit | 2.8 | 0.955 | -1.84 | 1.3 | 3.64 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 270 | 169 | 89.4 | 13.7 | 30.7 |
Operating Profit | -0.679 | -1.75 | -4.99 | -1.04 | -1.43 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.681 | -1.75 | -4.99 | -1.02 | -0.28 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.503 | -1.3 | -3.7 | -0.764 | -0.346 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.503 | -1.3 | -3.7 | -0.764 | -0.346 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.503 | -1.3 | -3.7 | -0.764 | -0.214 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.083 | -0.214 | -0.61 | -0.126 | -0.035 |